SEARCH

SEARCH BY CITATION

References

  • 1
    Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
  • 2
    Feder J, Tsuchihashi Z, Irrinki A, Lee V, Mapa F, Morikang E, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-14028.
  • 3
    Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-788.
  • 4
    Bridle K, Frazer D, Wilkins S, Dixon J, Purdie D, Crawford D, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003;361:661-673.
  • 5
    Bardou-Jacquet E, Philip J, Lorho R, Ropert M, Latournerie M, Houssel-Debry P, et al. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis. Hepatology 2014;59:839847.
  • 6
    Camaschella C. Treating iron overload. N Eng J Med 2013;368:2325-2327.
  • 7
    Garuti C, Tian Y, Montosi G, Sabelli M, Corradini E, Graf R, et al. Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. Gastroenterology 2010;139:315-322.
  • 8
    De Domenico I, Kushner JP. Reconstitution of normal hepcidin expression in Hfe-deficient mice after liver transplantation: a new role of HFE in Kupffer cells? Gastroenterology 2010;139:25-27.
  • 9
    Powell LW. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol 1992;16:259-261.
  • 10
    Adams PC, Ghent CN, Grant DR, Frei JV, Wall WJ. Transplantation of haemochromatosis liver into donor: evidence against an inherited intrahepatic defect. Gut 1991;32:1082-1083.
  • 11
    Adams PC, McAlister V, Chakrabarti S, Levstik M, Marotta P. Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosis. Can J Gastroenterol 2008;22:851-853.
  • 12
    Adams PC, Alanen K, Preshaw R, Chakrabarti S, Jeffrey G, Howson W, et al. Transplantation of haemochromatosis liver and intestine into a normal recipient. Gut 1999;45:783.
  • 13
    Kowdley K, Brandhagen D, Gish R, Bass N, Weinstein J, Schilsky M, et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005;129:494-503.
  • 14
    Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, et al. Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One 2012;7:e36425.
  • 15
    Pietrangelo A. Hereditary hemochromatosis. Annu Rev Nutr 2006;26:251-270.
  • 16
    Tan TC, Crawford DH, Franklin ME, Jaskowski LA, MacDonald GA, Jonsson JR, et al. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int 2012;32:1391-1399.
  • 17
    Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, et al. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat 2010;17:800-806.
  • 18
    Ramos E, Ruchala P, Goodnough JB, Kautz L, Preza GC, Nemeth E, et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 2012;120:3829-3836.
  • 19
    Phatak P, Brissot P, Bonkovsky H, Wurster M, Powell L, Niederau C, et al. A phase I/II, open-label, dose-escalation trial of once daily oral chelator deferasirox to treat iron overload in HFE-related hereditary hemochromatosis. Hepatology 2010;52:1671-1679.
  • 20
    Kautz L, Nemeth E, Ganz T. The erythroid factor erythroferrone and its role in iron metabolism. Am J Hematol 2013;88:E24. [Abstract].
  • 21
    Valenti L, Fracanzani AL, Rametta R, Fraquelli M, Soverini G, Pelusi S, et al. Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. J Hepatol 2012;57:1319-1325.